The Expert Advisory Group on AIDS had its first meeting. Read more about The Expert Advisory Group on AIDS had its first meeting.
The publication of the leaflet "AIDS and how it affects blood donors" was announced. Read more about The publication of the leaflet "AIDS and how it affects blood donors" was announced.
The Council of Europe's Committee of Ministers' resolution recommending "all necessary steps and measures with respect to" AIDS be taken was adopted. Read more about The Council of Europe's Committee of Ministers' resolution recommending "all necessary steps and measures with respect to" AIDS be taken was adopted.
Dr Galbraith wrote to the DHSS recommending the withdrawal of US blood products due to the risk of AIDS transmission. Read more about Dr Galbraith wrote to the DHSS recommending the withdrawal of US blood products due to the risk of AIDS transmission.
The line "no conclusive proof" first appeared in a briefing note to the Prime Minister. Read more about The line "no conclusive proof" first appeared in a briefing note to the Prime Minister.
Dr Gunson warned DHSS civil servants that there could be "considerable publicity [...] concerning the safety of American Factor VIII" Read more about Dr Gunson warned DHSS civil servants that there could be "considerable publicity [...] concerning the safety of American Factor VIII"
Dr Walford wrote in a DHSS minute that NANBH could "be rapidly fatal" and "lead to progressive liver damage". Read more about Dr Walford wrote in a DHSS minute that NANBH could "be rapidly fatal" and "lead to progressive liver damage".
Dr Yellowlees sent a 'Dear Doctor' letter to all Regional Medical Officers saying that collections from prisons could continue despite the higher risk of Hepatitis B if all donations were subjected to more sensitive Hepatitis B tests. Read more about Dr Yellowlees sent a 'Dear Doctor' letter to all Regional Medical Officers saying that collections from prisons could continue despite the higher risk of Hepatitis B if all donations were subjected to more sensitive Hepatitis B tests.
CSM requested the Licensing Authority to invite early applications for licence variations to permit distribution and sale of heat-treated concentrates. Read more about CSM requested the Licensing Authority to invite early applications for licence variations to permit distribution and sale of heat-treated concentrates.
It was confirmed that import of factor products made from higher risk pre-March plasma would continue. Read more about It was confirmed that import of factor products made from higher risk pre-March plasma would continue.